System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Stéphanie Truant is an expert in Surgery at Centre Hospitalier Universitaire de Lille (France). Stéphanie Truant has authored 281 publications, the most recent in 2026, and is an investigator in 18 clinical trials, 7 of them ongoing. SLR score: 857 (community average: 125). How the SLR is computed.

LeadR Profile

Stéphanie Truant Centre Hospitalier Universitaire de Lille France
857 ScienceLeadR Reputation 857

Unlock

Register Login
Network Map

Surgery

Subspecialties: Gastroenterology - Oncology - Hepatology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2003 - 2026
Source: PubMed

INSERM

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 281

Citations

Citations: 7 838 1st author: 30 Last author: 31 Unique author: 1

Main journals

HPB (Oxford) 40
Ann Surg 31
Br J Surg 14
Ann Surg Oncol 11
Hepatobiliary Surg Nutr 9

Best Journals

J Clin Oncol 2
Ann Oncol 1
J Hepatol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Does Surgical Approach Influence Benchmark Attainment in Intrahepatic Cholangiocarcinoma?
PMID 42496491 — mortality, lymph node excision, neoplasms, liver, general surgery, cholangiocarcinoma, intrahepatic cholangiocarcinoma		World J Surg20260
Evaluating quality of colorectal cancer surgery across elective and emergency health systems: secondary analysis of prospective cohort studies in 95 countries.
PMID 42483900 — global health, emergencies, surgical procedures, operative, neoplasms, income, cohort studies, colorectal neoplasms		BJS Open20260
Minimally invasive pancreatectomy with mesentericoportal venous resection: Results from a French national cohort.
PMID 42414185 — liver diseases, mortality, blood, operative time, morbidity, pancreatectomy		HPB (Oxford)20260
ASO Video Abstract: How to Deal with Median Arcuate Ligament during Pancreaticoduodenectomy? Management Strategies and Impact on Perioperative Outcomes.
PMID 42262425 — pancreaticoduodenectomy, ligaments		Ann Surg Oncol20260
FRIES score: predicting conversion in robotic liver surgery.
PMID 42258771 — minimally invasive surgical procedures, surgical procedures, operative, liver, postoperative complications		BJS Open20260

Clinical Studies 18

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 11
Phase 3 3
Phase 2 2
Phase 1/Phase 2 1
Phase 2/Phase 3 1

By status:

Completed 5
Recruiting 5
Unknown 5
Active not recruiting 2
Not yet recruiting 1

By type:

Interventional 10
Observational 8

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 0
multicentric5to9 0
multicentricup10 11

Main Topics

Cohort/Consortium Investigators 9

Ongoing Clinical Trials

7 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
metastatic colorectal cancer
2023-504831-42-00 — neoplasms, drug therapy, liver, neoplasm metastasis, therapeutics, colorectal neoplasms, chemotherapy		Phase 3Recruiting2025
Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy
NCT07547033 — surgical oncology, pancreaticoduodenectomy, neoplasms, adenocarcinoma, mesenteric artery, superior, arteries, pancreas, mesenteric arteries, gestures, dissection, surgeons, head		N/ANot yet recruiting2026
Risk adapted adjuvant chemotherapy guided by the tumour stage for operated pancreatic adenocarcinoma following neoadjuvant chemotherapy with FOLFIRINOX FRENCH26 PRODIGE93 PANACHE02 Trial
2024-519048-33-00 — adenocarcinoma, drug therapy, chemotherapy, adjuvant, therapeutics, chemotherapy		Phase 2/Phase 3Recruiting2025
PRODIGE 98 AMPIRINOX Randomized multicenter Phase III trial of adjuvant chemotherapy with modified FOLFIRINOX versus capecitabine or gemcitabine in patients with resected ampullary adenocarcinoma
2024-511070-68-01 — adenocarcinoma, drug therapy, chemotherapy, adjuvant, capecitabine, chemotherapy		Phase 3Recruiting2024
Safety of HRX215 in Patients After Minor and Major Liver Resection
NCT06638502 — pilots, safety, colon, duration of therapy, liver, hepatectomy, capsules, neoplasm metastasis, therapeutics, carcinoma		Phase 1/Phase 2Recruiting2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS